Clinical Trials Logo

Clinical Trial Summary

The study is a prospective single-blinded two-arms study that includes three treatment procedures and four follow-up visits


Clinical Trial Description

This study will evaluate the clinical efficacy and safety of the BTL-899 device for non-invasive lipolysis and circumference reduction of abdomen. The study is a prospective single-blinded two-arms study. The subjects will be enrolled and assigned into a two study groups. All subjects will complete three (3) treatment visits and will be invited to four (4) follow-up visits 1, 2, 3 and 6-months after the final treatment. 6-months follow-up visit is the optional one. ;


Study Design


Related Conditions & MeSH terms

  • Improvement of Abdomen Appearance

NCT number NCT04000945
Study type Interventional
Source BTL Industries Ltd.
Contact
Status Active, not recruiting
Phase N/A
Start date December 3, 2018
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT03270150 - Effect of the BTL-899 Therapy for Non-invasive Lipolysis and Circumference Reduction of Abdomen N/A
Completed NCT03923855 - Clinical Evaluation of the BTL-899 Device for Non-invasive Lipolysis on Human Fat Tissue N/A